SG Capital Management LLC Takes $30.29 Million Position in Maximus, Inc. (NYSE:MMS)

SG Capital Management LLC purchased a new stake in Maximus, Inc. (NYSE:MMS - Free Report) in the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The fund purchased 405,689 shares of the health services provider's stock, valued at approximately $30,285,000. Maximus makes up 2.9% of SG Capital Management LLC's investment portfolio, making the stock its 7th biggest holding. SG Capital Management LLC owned about 0.71% of Maximus at the end of the most recent quarter.

Several other hedge funds also recently made changes to their positions in the stock. UMB Bank n.a. grew its position in shares of Maximus by 79.8% in the fourth quarter. UMB Bank n.a. now owns 356 shares of the health services provider's stock valued at $27,000 after purchasing an additional 158 shares in the last quarter. V Square Quantitative Management LLC grew its position in shares of Maximus by 65.9% in the fourth quarter. V Square Quantitative Management LLC now owns 453 shares of the health services provider's stock valued at $34,000 after purchasing an additional 180 shares in the last quarter. Hillsdale Investment Management Inc. grew its position in shares of Maximus by 0.4% in the fourth quarter. Hillsdale Investment Management Inc. now owns 52,400 shares of the health services provider's stock valued at $3,912,000 after purchasing an additional 230 shares in the last quarter. Bridge City Capital LLC grew its position in shares of Maximus by 0.9% in the fourth quarter. Bridge City Capital LLC now owns 28,503 shares of the health services provider's stock valued at $2,128,000 after purchasing an additional 254 shares in the last quarter. Finally, Inspire Advisors LLC grew its position in shares of Maximus by 3.1% in the fourth quarter. Inspire Advisors LLC now owns 8,650 shares of the health services provider's stock valued at $646,000 after purchasing an additional 258 shares in the last quarter. 97.21% of the stock is currently owned by hedge funds and other institutional investors.

Maximus Price Performance

NYSE:MMS traded up $0.17 during trading hours on Monday, hitting $75.16. 342,414 shares of the company's stock traded hands, compared to its average volume of 561,468. The firm has a market cap of $4.24 billion, a P/E ratio of 16.16 and a beta of 0.61. Maximus, Inc. has a 52 week low of $63.77 and a 52 week high of $93.97. The business's fifty day simple moving average is $68.88 and its two-hundred day simple moving average is $72.47. The company has a quick ratio of 1.72, a current ratio of 1.72 and a debt-to-equity ratio of 0.82.

Maximus (NYSE:MMS - Get Free Report) last posted its quarterly earnings data on Thursday, May 8th. The health services provider reported $2.01 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.37 by $0.64. The company had revenue of $1.36 billion during the quarter, compared to analyst estimates of $1.29 billion. Maximus had a return on equity of 21.95% and a net margin of 5.28%. The firm's quarterly revenue was up 1.0% on a year-over-year basis. During the same quarter last year, the company earned $1.57 earnings per share. On average, research analysts anticipate that Maximus, Inc. will post 6.15 earnings per share for the current fiscal year.

Maximus Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Saturday, May 31st. Investors of record on Thursday, May 15th will be paid a dividend of $0.30 per share. This represents a $1.20 annualized dividend and a yield of 1.60%. The ex-dividend date of this dividend is Thursday, May 15th. Maximus's dividend payout ratio is 23.86%.

Insider Activity at Maximus

In other Maximus news, Director Jan Madsen sold 2,439 shares of Maximus stock in a transaction dated Tuesday, March 18th. The stock was sold at an average price of $67.71, for a total transaction of $165,144.69. Following the completion of the sale, the director now owns 18,097 shares of the company's stock, valued at $1,225,347.87. The trade was a 11.88% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, insider Ilene R. Baylinson sold 14,500 shares of Maximus stock in a transaction dated Wednesday, February 19th. The stock was sold at an average price of $68.14, for a total value of $988,030.00. Following the sale, the insider now directly owns 2,512 shares of the company's stock, valued at approximately $171,167.68. This trade represents a 85.23% decrease in their position. The disclosure for this sale can be found here. 1.60% of the stock is owned by corporate insiders.

Wall Street Analysts Forecast Growth

Separately, StockNews.com cut Maximus from a "buy" rating to a "hold" rating in a research report on Thursday.

Maximus Company Profile

Maximus, Inc operates as a provider of government services in the United States and internationally. It operates through three segments: U.S. Federal Services, U.S. Services, and Outside the U.S. The U.S. Services segment offers program eligibility support and enrollment; centralized multilingual customer contact centers, multichannel, and digital self-service options for enrollment; application assistance and independent health plan choice counseling; beneficiary outreach, education, eligibility, enrollment, and redeterminations; and person-centered independent disability, long-term sick, and other health assessments.